Atlas Trials

Inclusion Body Myopathy 2

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Inclusion Body Myopathy 2

RecordFirmDate
A Study to Evaluate the Safety of Aceneuramic Acid Extended Release (Ace-ER; UX001) Tablets in Glucosamine (UDP-N-acetyl)-2-Epimerase (GNE) Myopathy (GNEM) (Also Known as Hereditary Inclusion Body Myopathy [HIBM]) Patients With Severe Ambulatory Impairment (NCT02731690)Ultragenyx Pharmaceutical Inc2016-04-29

Track Inclusion Body Myopathy 2 automatically

Every clearance here is in the API, with alerts when new ones post.